No products in the cart.
MODULE 37: LOOK-ALIKE / SOUND-ALIKE (LASA) & HIGH-ALERT DRUG SAFETY
Section 37.2: Labeling, Storage, and ADC Configuration Strategies
Discover the practical tools of error prevention. This section covers the use of warning labels, strategic segregation of high-risk drugs in the pharmacy and ADCs, and configuring technology to build safety nets.
SECTION 37.2
Labeling, Storage, and ADC Configuration Strategies
Building a Fortress of Safety with Practical Tools.
37.2.1 The “Why”: From Passive Recognition to Active Prevention
In the previous section, we retrained our eyes to identify the inherent risks in medication names and packaging. That is the essential first step of diagnosis. This section is about treatment. Knowing that hydromorphone and morphine are a dangerous LASA pair is knowledge; physically separating them in the automated dispensing cabinet and placing a bright orange “HIGH-ALERT: HIGH POTENCY” sticker on the hydromorphone bin is an action. It is the tangible implementation of a safety strategy. This is the core principle of this section: we are moving from passive risk identification to the active, physical, and digital manipulation of the environment to make it harder for people to do the wrong thing and easier for them to do the right thing.
Think of these strategies as layers of defense. A single strategy may fail, but multiple, redundant layers create a robust safety net. A busy nurse might not notice the Tall-Man lettering on an ADC screen, but they might be stopped by the bright red warning label on the bin lid, or by the fact that the dangerous drug is stored in a completely different area than they expected. As a pharmacist, you are one of the primary architects of this layered defense system. Your expertise in configuring ADCs, designing clear and effective labels, and organizing the pharmacy for safety is one of the most powerful contributions you can make to patient care, preventing countless errors from ever having the chance to occur.
Retail Analogy: Designing a Safer Backroom
Imagine you’ve taken over a pharmacy with a chaotic backroom. Fast-moving drugs are stored randomly, refrigerated items are mixed in with room-temp stock, and controlled substances are hard to locate. Your first week, you just observe the chaos (Section 1). Your second week, you start to impose order (Section 2). You don’t just tell your technicians to “be more careful”; you give them a better system.
You create a dedicated, clearly marked area for fast-movers. You put bright orange stickers on all the insulin boxes in the fridge. You move the high-value items to a more secure location. You create a visual system with bin labels and dividers so anyone can see at a glance where a drug is supposed to go. You are not changing the drugs themselves; you are changing the environment in which people interact with the drugs. You are using visual cues, location, and organization as tools to reduce the cognitive load on your team and prevent errors before they happen. This is exactly what we will do with the entire hospital medication system.
37.2.2 The Power of the Label: Communicating Risk at a Glance
In a busy clinical environment, attention is a scarce resource. A well-designed auxiliary label is a powerful tool because it communicates a critical piece of information without requiring the user to read a lengthy package insert. It’s a visual “shout” that says, “Pay attention! This drug is different!” Your role is to ensure these labels are used consistently, appropriately, and not overused to the point of “alert fatigue.”
Masterclass Table: Essential Auxiliary Labels for Hospital Safety
| Label Type & Visual Cue | Purpose & When to Use | Specific Risk Mitigated | Pharmacist’s Action & Example |
|---|---|---|---|
| HIGH-ALERT (Bright Red or Orange) |
To identify medications on the ISMP or hospital’s specific High-Alert list that carry an increased risk of causing significant patient harm when used in error. | Prevents inadvertent mix-ups and serves as a cognitive stop sign, prompting the user to pause and double-check before proceeding. | Apply to storage bins and individual products for all high-alert drugs. Example: Every vial of insulin, every bag of concentrated potassium chloride, and every prefilled syringe of epinephrine should have a “HIGH-ALERT” sticker. |
| TALL-MAN LETTERING (e.g., hydrOXYzine) |
Applied to known LASA pairs to draw attention to the dissimilar parts of the names, breaking the confirmation bias loop. | Reduces the likelihood of a user grabbing the wrong product based on familiarity with the first few letters of the name. | Generate and apply shelf labels with approved Tall-Man lettering for all designated pairs. Example: The shelf label for dopamine should read “DOPamine” and the one for dobutamine should read “DOBUTamine”. |
| FOR [ROUTE] USE ONLY (e.g., “FOR IV USE ONLY”) |
To prevent catastrophic wrong-route errors, especially for medications that can be administered multiple ways or are toxic if given incorrectly. | Prevents fatal errors like giving an oral solution intravenously or an IV medication intrathecally. | This is non-negotiable for certain preparations. Example: All epidural bags must be labeled “FOR EPIDURAL USE ONLY.” All oral syringes should be labeled “FOR ORAL USE ONLY.” All vincristine minibags must be labeled “FATAL IF GIVEN INTRATHECALLY – FOR IV USE ONLY.” |
| HAZARDOUS DRUG (Bright Yellow/Chemo Glove) |
To comply with USP <800> and protect healthcare workers from exposure to hazardous medications (e.g., chemotherapy, antivirals, hormonal agents). | Ensures proper handling, transport, and disposal procedures are followed, minimizing occupational exposure. | Apply to storage bins and outer packaging for all drugs on the NIOSH hazardous drug list. Example: Bins containing methotrexate tablets or vials of fluorouracil must have a “Hazardous Drug” or “Chemotherapy” label. |
| REFRIGERATE (Blue with Snowflake) |
To ensure medications that require cold-chain storage are not left at room temperature, which can lead to loss of potency. | Prevents administration of sub-potent medications, which is a critical failure for drugs like vaccines, certain antibiotics, and biologic agents. | Apply to all refrigerated medication bins and sometimes to the products themselves. This is a crucial visual cue for technicians restocking ADCs or nurses pulling medications. |
| PARALYTIC AGENT (Fluorescent Red/Orange) |
To identify neuromuscular blocking agents, which can cause complete respiratory arrest if given to a patient who is not ventilated. | Prevents the catastrophic error of accidentally paralyzing a conscious, breathing patient. This is one of the highest-risk medication errors. | Must be applied to every vial, syringe, and storage bin of paralytics like succinylcholine, rocuronium, and vecuronium. The label should read “WARNING: PARALYZING AGENT – CAUSES RESPIRATORY ARREST.” |
37.2.3 Strategic Segregation: The Power of Place
Where you store a medication can be just as important as how you label it. Storing two look-alike drugs side-by-side is an invitation for a slip-based error, no matter how good the labels are. Strategic segregation is the practice of using physical space as a safety tool.
Key Segregation Strategies
- Segregation by Route of Administration: This is a fundamental principle. Oral medications should never be stored intermingled with injectable medications. Within injectables, IV medications should be separate from IM, subcutaneous, and especially intrathecal or epidural medications. This creates a powerful physical barrier against wrong-route errors.
-
Dedicated Storage for High-Alert Drug Classes: Certain classes of medications are so high-risk they deserve their own, isolated storage areas.
- Neuromuscular Blockers (Paralytics): These should be stored in a completely separate, lidded, and labeled container in any area they are kept (e.g., the ADC, the OR, the IV room). They should NEVER be in an open matrix drawer next to other medications.
- Insulins: In the pharmacy refrigerator and in ADCs, all insulins should be stored together, but segregated from other refrigerated drugs. Within the insulin storage area, different types (rapid, short, intermediate, long-acting) should be further separated to prevent mix-ups.
- Concentrated Electrolytes: Concentrated potassium chloride, sodium chloride (>0.9%), and magnesium sulfate should be removed from all general patient care areas and stored only in the pharmacy. This is a Joint Commission National Patient Safety Goal.
- Separating LASA Pairs: Do not store known look-alike or sound-alike pairs in adjacent bins, pockets, or drawers. If hydrALAZINE is in drawer 3, pocket A, put hydrOXYzine in drawer 10, pocket G. The goal is to force the user to go to a different physical location, breaking the automaticity and forcing a conscious thought process.
- Quarantining High-Concentration Formulations: When multiple concentrations of a drug exist (e.g., Heparin 1,000 units/mL vs. Heparin 10,000 units/mL), the higher, more dangerous concentrations should be stored separately, ideally in the pharmacy only, with clear warnings. Avoid storing multiple concentrations in the same ADC if at all possible.
37.2.4 Configuring the ADC for Safety: Your Digital Fortress
The Automated Dispensing Cabinet is one of the most powerful safety tools at your disposal—if configured correctly. As a pharmacist, you often have a key role in managing the ADC database. This is your opportunity to build digital guardrails that guide users toward safe practices.
Masterclass Table: ADC Safety Configuration
| Configuration Type | Strategy | Why It Matters & Pharmacist’s Action |
|---|---|---|
| Physical Layout | Map the ADC Like a Safety Engineer. Implement the segregation strategies from the previous section. Never place LASA pairs or different concentrations of the same drug in adjacent pockets. Place high-alert drugs in single-item, lidded compartments that force a user to open them individually. |
This is your first and most powerful line of defense. Action: Regularly run reports of your ADC layouts and actively “hunt” for dangerous adjacencies. Propose layout changes to the pharmacy leadership or medication safety committee. |
| Drug Profile & Information | Use Digital Tall-Man Lettering. Ensure that the drug name displayed on the ADC screen for all ISMP-approved LASA pairs is programmed with Tall-Man lettering (e.g., DOBUTamine vs DOPamine). |
This reinforces the visual differentiation at the critical moment of selection. Action: Audit your ADC drug database against the ISMP’s official list and submit change requests for any discrepancies. |
| Alerts & Warnings | Create Custom Pop-Up Alerts. Build clear, concise, and actionable alerts for high-risk medications. For example, when a nurse pulls rocuronium, an alert should pop up saying: “WARNING: PARALYZING AGENT. Patient must be intubated and ventilated.” |
Well-designed alerts serve as a final cognitive check. Avoid vague alerts. They must state the risk and the required action. Action: Work with the medication safety team to develop a standardized library of ADC alerts for your hospital’s highest-risk drugs. |
| Limit “Alert Fatigue.” Do not create alerts for every medication. Over-alerting teaches users to ignore all warnings. Reserve pop-up alerts for only the most critical, high-risk scenarios where an error would be catastrophic. |
If everything is an emergency, nothing is an emergency. Action: Periodically review your list of ADC alerts. Are they all necessary? Can some be converted to less intrusive label-based warnings? | |
| Inventory & Access Controls | Set Clinically Appropriate PAR Levels. The PAR level is the quantity of a drug stocked in the ADC. For high-alert drugs, keep PAR levels low (e.g., only one or two vials of concentrated heparin) to minimize the risk of a massive overdose or the wrong drug being pulled for multiple patients. |
Limiting the quantity available minimizes the potential harm from a single error. Action: Review PAR levels for high-alert drugs. If you see an ADC stocked with 10 vials of insulin glargine, question if that quantity is truly needed and propose a reduction. |
| Security & Tracking | Require a “Blind Count” for Removals. For controlled substances and some high-alert drugs, configure the ADC to require the nurse to count the remaining quantity in the pocket *before* they are shown the expected quantity. This forces an active count rather than a passive confirmation. |
This significantly improves the accuracy of controlled substance counts and helps detect diversion or incorrect removals more quickly. Action: Advocate for the use of blind counts on all controlled substances and potentially on other high-risk, high-cost medications. |
Putting It All Together: A Layered Defense in Action
Imagine a nurse needs to pull hydromorphone from an ADC. Here is how our layered system works to prevent a mix-up with morphine:
- System Layer 1 (Storage): Morphine is stored in drawer 1. Hydromorphone is in a separate, lidded compartment in drawer 5. The physical separation prevents a simple “grab the adjacent vial” slip.
- System Layer 2 (Technology): On the ADC screen, the nurse sees “HYDROmorphone” in Tall-Man lettering, visually distinguishing it from Morphine.
- System Layer 3 (Labeling): As the lidded compartment for hydromorphone opens, the nurse sees a bright orange bin liner and a sticker that says “HIGH-ALERT / HIGH POTENCY OPIOID.”
- System Layer 4 (Packaging): The vial itself may have an auxiliary sticker from the pharmacy also stating “HIGH-ALERT.”
At any one of these four steps, an attentive nurse could catch a potential error. The power of the system is that even a distracted or rushed nurse is likely to be stopped by at least one of these layers. This is the essence of building a resilient safety system.
